#5 Up and to the right: How Limbic is tackling the supply-demand problem of mental health care
plus... Akili & Virtual Therapeutics merger, $12m fundraise for maternal mental health, a spotlight on Flow Neuroscience and all the latest news in mental health innovation
Hi friends,
If you’re new here, welcome!
I'm Steve Duke and this is where I write about what is happening in mental health innovation.
My goal? To give founders and operators actionable insights they can use to maximise their impact in mental health.
A few weeks ago I wrote about Limbic, the UK based company developing mental health AI tech. They had just raised $14m in a round led by Khosla Ventures and the more I read about them, the more I was intrigued.
Their product had been adopted by 40% of NHS Talk Therapy providers with over 280,000 patients using it. They’d also published a bunch of impressive research supporting positive clinical outcomes.
I wanted to learn more.
What was the story behind this company, what were they getting right and what were they planning for the future?
So I caught up with Ross Harper, CEO and Co-Founder of Limbic for a chat.
In today’s post, we go deep on Limbic, sharing insights from Ross on what makes Limbic special and how they think about addressing our mental health crisis.
This week in The Hemingway Report:
Limbic: their approach to tackling the supply-demand problem of mental health care and what we can learn from them
Maternal Mental Health: the startup that just raised $12.6m to expand virtual mental health services to women on their parenthood journey.
Our Mental Health Funding Database: in case you missed it… we made a database of all mental health investors and grants which you can access for free.
Flow Neuroscience: The company developing at-home brain stimulation headsets to reduce symptoms of depression.